Terbaiklah, shareholders mau :)


@Good123 Mlabs Systems Entered Digital Distribution Agreement With Mtouche International

Nov 19 (Reuters) - Mlabs Systems Bhd <MLBS.KL>::ENTERED DIGITAL DISTRIBUTION AGREEMENT WITH MTOUCHE INTERNATIONAL SDN. BHD.AGREEMENT EXPECTED TO HAVE POSITIVE CONTRIBUTION TO EARNINGS AND NET ASSETS OF GROUP.AGREEMENT TO PROMOTE, MARKET, & DISTRIBUTE NOVEL CORONAVIRUS RP-PCR DETECTION & DIAGNOSTIC KIT, AMONG OTHERS.
11/12/2020 10:05 AM

Good123 Mlabs Systems Says Unit To Acquire Property For 7 Mln RGT

Sept 24 (Reuters) - Mlabs Systems Bhd <MLBS.KL>::UNIT NEXT GEN BIOSCIENCES SDN BHD TO ACQUIRE PROPERTY FROM VENUS ASSETS SDN BHD FOR 7 MILLION RGT.
11/12/2020 10:06 AM

Good123 PM membuat kenyataan tentang Vaksin namun tidak memacakkan harga kerana beberapa faktor dalam kaunter yang terlibat.

Saya fikir rally akan kick start minggu depan setidaknya kaunter MTOUCH jika KANGER masih dalam urusan PP dan pullback yang belum sempurna.

Berita Pfizer sangat dekat dengan MTOUCH apabila Mr Tan Boon Koon, executive director MTOUCH pada 13nov2020 mengatakan melalui Shanghai Fosun Long March rakan pengilangnya telah berbincang dengan induknya Shanghai Fosun Pharmaceutical Group untuk mengedarkan Vaksin dari kerjasama antara Biontech dari German dan Pfizer dari USA.

Di masa ini testkid edaran MTOUCH telah mendapat kelulusan MOH untuk di gunakan.

Nexgram akan melakukan di lapangan dan MLABS Sebagai makmal pemprosesan sample.
11/12/2020 10:08 AM

Ya lah, jika ordinary share price tak naik, harga warrant pun tak baik.

Waiting for action, let’s see later

RI was oversubscribed ~7% ingat :)


NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING MLABS SYSTEMS BERHAD ("MLABS" OR THE "COMPANY") RIGHTS ISSUE WITH WARRANTS

MLABS SYSTEMS BERHAD

Type Announcement
Subject NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description MLABS SYSTEMS BERHAD ("MLABS" OR THE "COMPANY")

RIGHTS ISSUE WITH WARRANTS
(For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Abridged Prospectus dated 13 November 2020 issued by the Company in relation to the Rights Issue with Warrants.)



We refer to the Abridged Prospectus dated 13 November 2020.



On behalf of the Board, Mercury Securities wishes to announce that pursuant to the close of acceptance, excess applications and payment for the Rights Shares with Warrants C at 5.00 p.m. on 30 November 2020, the Company had received valid acceptances and excess applications for a total of 806,441,306 Rights Shares, representing an over-subscription of 6.8% over the total number of Rights Shares available for subscription under the Rights Issue with Warrants.



Details of such valid acceptances and excess applications received are as follows:-





No. of Rights Shares

% of total issue

Total valid acceptances

621,805,762

82.3

Total valid excess applications

184,635,544

24.5

Total valid acceptances and excess applications

806,441,306

106.8

Total Rights Shares available for subscription

755,123,220

100.0

Over-subscription

51,318,086

6.8


Successful applicants of the Rights Shares will be given Warrants C on the basis of 7 Warrants C for every 12 Rights Shares successfully subscribed for. The Excess Rights Shares with Warrants C will be allotted in a fair and equitable manner in the following priority:-



(i) firstly, to minimise the incidence of odd lots;



(ii) secondly, on a pro-rata basis and in board lots, to the Entitled Shareholders who have applied for Excess Rights Shares with Warrants C, taking into consideration their respective shareholdings in the Company as at the Entitlement Date;



(iii) thirdly, on a pro-rata basis and in board lots, to the Entitled Shareholders who have applied for Excess Rights Shares with Warrants C, taking into consideration the quantum of their respective Excess Rights Shares with Warrants C Applications; and



(iv) finally, on a pro-rata basis and in board lots, to the transferee(s) and/or renouncee(s) who have applied for Excess Rights Shares with Warrants C, taking into consideration the quantum of their respective Excess Rights Shares with Warrants C Applications.



The Excess Rights Shares with Warrants C will firstly be allocated to minimise the odd lots (if any) held by each applicant of Excess Rights Shares with Warrants C. Thereafter, the allocation process will perform items (ii), (iii) and (iv) in succession. Any remaining balance of Excess Rights Shares with Warrants C will be allocated by performing the same sequence of allocation i.e. items (ii), (iii) and (iv) again in succession until all Excess Rights Shares with Warrants C are allotted.



Notwithstanding the foregoing, the Board reserves the right to allot any Excess Rights Shares with Warrants C applied for under Part I(B) of the RSF in such manner as it deems fit and expedient and in the best interests of the Company subject always to such allocation being made on a fair and equitable basis, and that the intention of the Board as set out in (i), (ii), (iii) and (iv) above is achieved. The Board also reserves the right at its absolute discretion not to accept any application for Excess Rights Shares with Warrants C, in full or in part, without assigning any reason thereof.



The Rights Shares and Warrants C are expected to be listed on the ACE Market of Bursa Securities on 14 December 2020.



This announcement is dated 7 December 2020.

Yup Help your related party, mlab :)

Let's see the average cost per share based on 20 shares purchased before consolidation. THE BASIS OF 12 RIGHTS SHARES TOGETHER WITH 7 FREE WARRANTS C FOR EVERY 2 MLAB SHARES HELD.

20 mlab shares (bought at 2sen on the last day before consolidation) = 20 x 2 sen =40sen for 2 shares.

Subscribe for 12 shares under RI = 12 x 9sen = RM1.08.

Average cost per share = RM1.48/14 ~10.57sen

Harga kini 10sen = RUGI. If bought higher than 2sen before last day for consolidation, rugi lagi besar :)


Andaikan 7 free warrant bagi 12 RI shares subscribed, nilai warrant jika syer biasa masih 10sen= 7 x 1sen = 7 sen.

7sen / 14 shares = 0.5sen per share.


Jadi, kos per syer bersih ~ 10.57sen - 0.5sen ~ 10.07sen


Masih Rugi, jika kos belian sesaham sebelum konsolidasi melebihi 2 sen, rugi lagi besar.


Wait n see, semua pihak rugi termasuk major shareholders kan? :)



Semua pihak rugi termasuk pekerja :)

Issues, Repurchases, and Repayments of Debt and Equity Securities
There is no issues, repurchases, and repayments of debts and equity securities of the Group during the current
financial quarter and period except for:-


i. On 6 July 2020, the Company announced the fixed issue price of 110,000,000 private placement shares
at RM0.0318 each and were issued on 8th July 2020.
ii. On 7 July 2020, the Company announced the fixed issue price of 57,365,000 private placement shares
at RM0.0452 each and were issued on 21st July 2020.

iii. On 17 July 2020, 65,000,000 shares option were offered to eligible employee at an exercise price of
RM0.05 each and were issued on 6th August 2020.



Events after the End of the Quarter
i. On 1 September 2020, the Company proposed to consolidate of every 10 existing ordinary shares in the
Company into 1 share. The consolidation had been completed on 5 November 2020, in which 1,258,539,027
shares had consolidated into 125,853,870 Consolidated Shares.
ii. On 1 September 2020, the Company proposed renounceable right issue of up to 755,123,412 new shares
together with up to 440,488,657 free detachable warrants in the Company (“Warrant C”) on the basis of 12
Rights Shares together with 7 free Warrants C for every 2 existing shares. The abridged prospectus has been
released to the public on 13 November 2020. The closing date for acceptance and payment for provisional
allotment and excess Rights Shares is on 30 November 2020.
iii. On 6 October 2020 and 11 November 2020, the Company subscribed Redeemable Convertible Preference
Shares (“RCPS”) in Longhouse Films Sdn Bhd (“Longhouse”) amounted to RM1,000,000.
iv. On 19 November 2020, Mlabs Research Sdn Bhd (“Research”), a wholly owned subsdiary of the Company
had entered into a Digital Distribution Agreement with mTouche International Sdn Bhd to promote, market,
and distribute Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel
Coronavirus (SAR-CoV-2) lgM/lgG Rapid Test Kit, and other equivalent products in Malaysia and South
East Asia Region only through the Group’s digital distribution channel.

Let's see the average cost per share based on 20 shares purchased before consolidation. THE BASIS OF 12 RIGHTS SHARES TOGETHER WITH 7 FREE WARRANTS C FOR EVERY 2 MLAB SHARES HELD.

20 mlab shares (bought at 2sen on the last day before consolidation) = 20 x 2 sen =40sen for 2 shares.

Subscribe for 12 shares under RI = 12 x 9sen = RM1.08.

Average cost per share = RM1.48/14 ~10.57sen

Harga kini 10sen = RUGI. If bought higher than 2sen before last day for consolidation, rugi lagi besar :)


Andaikan 7 free warrant bagi 12 RI shares subscribed, nilai warrant jika syer biasa masih 10sen= 7 x 1sen = 7 sen.

7sen / 14 shares = 0.5sen per share.


Jadi, kos per syer bersih ~ 10.57sen - 0.5sen ~ 10.07sen


Masih Rugi, jika kos belian sesaham sebelum konsolidasi melebihi 2 sen, rugi lagi besar.


Wait n see, semua pihak rugi termasuk major shareholders kan? :)



Semua pihak rugi termasuk pekerja :)

Issues, Repurchases, and Repayments of Debt and Equity Securities
There is no issues, repurchases, and repayments of debts and equity securities of the Group during the current
financial quarter and period except for:-


i. On 6 July 2020, the Company announced the fixed issue price of 110,000,000 private placement shares
at RM0.0318 each and were issued on 8th July 2020.
ii. On 7 July 2020, the Company announced the fixed issue price of 57,365,000 private placement shares
at RM0.0452 each and were issued on 21st July 2020.

iii. On 17 July 2020, 65,000,000 shares option were offered to eligible employee at an exercise price of
RM0.05 each and were issued on 6th August 2020.



Events after the End of the Quarter
i. On 1 September 2020, the Company proposed to consolidate of every 10 existing ordinary shares in the
Company into 1 share. The consolidation had been completed on 5 November 2020, in which 1,258,539,027
shares had consolidated into 125,853,870 Consolidated Shares.
ii. On 1 September 2020, the Company proposed renounceable right issue of up to 755,123,412 new shares
together with up to 440,488,657 free detachable warrants in the Company (“Warrant C”) on the basis of 12
Rights Shares together with 7 free Warrants C for every 2 existing shares. The abridged prospectus has been
released to the public on 13 November 2020. The closing date for acceptance and payment for provisional
allotment and excess Rights Shares is on 30 November 2020.
iii. On 6 October 2020 and 11 November 2020, the Company subscribed Redeemable Convertible Preference
Shares (“RCPS”) in Longhouse Films Sdn Bhd (“Longhouse”) amounted to RM1,000,000.
iv. On 19 November 2020, Mlabs Research Sdn Bhd (“Research”), a wholly owned subsdiary of the Company
had entered into a Digital Distribution Agreement with mTouche International Sdn Bhd to promote, market,
and distribute Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel
Coronavirus (SAR-CoV-2) lgM/lgG Rapid Test Kit, and other equivalent products in Malaysia and South
East Asia Region only through the Group’s digital distribution channel.

Exercise price for warrant=9sen, Market price for ordinary share now = 10sen, Warrant price should be 1 sen when open for trading unless the ordinary share price rises / improves further today

A blessing in disguise :)

Social distancing SOPs had been imposed in Malaysia to curb the rise of Covid-19 cases, with the restriction in
movement and other measures limiting the close contact of people. However, the Group sees this as an
opportunity to grow the multimedia video conferencing business as it has been an important communication tool
to connect clients, colleagues, business partners and other stakeholders. The Group intends to expand the video
conferencing business by collaborating into the field of telemedicine as well as broadcasting and livestreaming.
Nevertheless, the Group continues to explore potential investment or acquisition in complementary business or
asset.
At this juncture, the Group is in discussion for potential collaboration of providing video conferencing facilities
to healthcare providers. The succession of this collaboration is expected to provide a stable and recurring income
stream via the monthly subscription fees. The demand for telemedicine is expected to grow in future
corresponding to the increase in the demand of healthcare services.
The Group had in August 2020 acquired a 51% equity interest by way of ordinary share subscription and
subscription of RCPS up to RM3.0 million in Longhouse, a film production company. The rationale for investing
into a film production company is to capitalise on the availability of government grants to encourage local film
production and to leverage on our existing technological capabilities that can be applied in film production.
The Group will continuously seek opportunities to expand its business in the ICT industry, complementing the
current business and tap into the ongoing trend of digitalisation of the economy.

Showing leapfrogging improvement even during pandemic period :)

Material Changes in Financial Performance for the Quarter Compared with Immediate Preceding
Quarter
Quarter Ended Changes (%)
30.09.2020 30.06.2020
Group Results
RM’000
(unaudited)
RM’000
(unaudited)
Revenue 2,986 822 >100%
Gross profit 827 321 >100%


The Group registered higher revenue of RM2.98 million in the current financial quarter compared to immediate
preceding financial quarter of RM0.82 million. The higher revenue and gross profit are mainly generated from
our subsidiary Inbase.

Ada berita baru mengenai bisnesnya di Hongkong dan China tak lama lagi kut?

On 15 July 2020, Champagne Carbon Asia Limited incorporated a wholly owned subsidiary, Shenzhen Carbon
Champagne Development Limited (“SCCDL”) with a registered paid up capital of RMB1,000,000.
On 10 August 2020, the Company subscribed 52,000 new ordinary shares at RM1.00 for a total consideration
of RM52,000 representing 51% shareholdings of Longhouse. Upon completion, Longhouse became a 51%
On 7 September 2020, the Company subscribed 150,000 new ordinary share at HKD1.00 for total consideration
of HKD150,000 representing 60% shareholdings of Linkodes International Limited.

Mlabs operates in promising markets

Geographical segments
The business segment is managed in few principal locations namely Malaysia, Thailand, China and Taiwan

~30 cash + cash from RI ~ RM100mil cash & cash equivalents sekarang kan?.

MLABS SYSTEMS BERHAD
Company No. 200401014724 (653227-V)
(Incorporated in Malaysia)
CONSOLIDATED INTERIM FINANCIAL STATEMENTS
FOR THE QUARTER ENDED 30 SEPTEMBER 2020

CASH AND CASH EQUIVALENTS
Net changes 6,428 (8,822)
Effects of changes in foreign exchange rate 303 3
Brought forward 22,490 22,591
Carried forward 29,221 13,772
Cash and cash equivalents at the end of the financial period comprise the following:
Cash and bank balances and short-term funds 29,221 13,772

RSI(14) Neutral 37.7
Stochastic(14) Oversold 7.7
Average Volume 31,585,800
Relative Volume 1.0

Semua pihak rugi :)

FIRST UNITED TECHNOLOGY LIMITED 20-Nov-2019 Acquired 8,000,000 0.000 View Detail
NETX HOLDINGS BERHAD 20-Nov-2019 Acquired 8,000,000 0.000 View Detail
FIRST UNITED TECHNOLOGY LIMITED 19-Nov-2019 Acquired 10,000,000 0.000 View Detail
NETX HOLDINGS BERHAD 19-Nov-2019 Acquired 10,000,000 0.000 View Detail
FIRST UNITED TECHNOLOGY LIMITED 18-Nov-2019 Acquired 26,500,000 0.000 View Detail
NETX HOLDINGS BERHAD 18-Nov-2019 Acquired 26,500,000 0.000 View Detail
FIRST UNITED TECHNOLOGY LIMITED 15-Nov-2019 Acquired 24,600,000 0.000 View Detail
NETX HOLDINGS BERHAD 15-Nov-2019 Acquired 24,600,000 0.000 View Detail
FIRST UNITED TECHNOLOGY LIMITED 27-Jun-2018 Acquired 7,000,000 0.000 View Detail
NETX HOLDINGS BERHAD 27-Jun-2018 Acquired 7,000,000 0.000 View Detail
FIRST UNITED TECHNOLOGY LIMITED 25-Jun-2018 Acquired 6,000,000 0.000 View Detail
NETX HOLDINGS BERHAD 25-Jun-2018 Acquired 6,000,000 0.000 View Detail
FIRST UNITED TECHNOLOGY LIMITED 22-Jun-2018 Acquired 3,000,000 0.000 View Detail
NETX HOLDINGS BERHAD 22-Jun-2018 Acquired 3,000,000 0.000 View Detail
ASIA BIOENERGY TECHNOLOGIES BERHAD 15-Sep-2017 Notice of Interest 75,100,000 0.000 View Detail
ASIABIO CAPITAL SDN. BHD. 15-Sep-2017 Notice of Interest 75,100,000 0.000 View Detail
FIRST UNITED TECHNOLOGY LIMITED 15-Sep-2017 Notice of Interest 48,100,000 0.000 View Detail
NETX HOLDINGS BERHAD 15-Sep-2017 Notice of Interest 48,100,000 0.000 View Detail
ACE SOLUTION INVESTMENTS LIMITED 28-Aug-2012 Notice of Interest 10,000,000 0.000 View Detail
BENJAMIN LIM KEONG HOE 28-Aug-2012 Notice of Interest 10,000,000 0.000 View Detail

Saya rasa many good news on the way, Hurray! :)

Canggih, mungkin new substantial shareholders kelak selepas RI nanti probably next week dah tahu lagi canggih daripada mlabs :)


MLABS SHARE TO TRADE HIGHER ON GLOVE AND HEALTHCARE NEWS


Another new player in glove manufacturing is Bursa-listed Mlabs System Bhd.



We hear that Mlabs will be working in partnership with an existing glove maker who is seeking expansion to meet global demand for medical or nitrile gloves due to the Covid-19 pandemic.


There continued to be growing demand for medical gloves globally and this requirement may outpace the supply available for front-line and healthcare organisations during the outbreak.


Malaysia is the world’s largest source of medical gloves, with a market share of about 65 per cent. This year alone local manufacturers are expected to produce 240 billion pieces of gloves because of Covid-19.





The number of Covid-19 cases around the world are rising. There are currently 13.1 million confirmed Covid-19 cases worldwide, and the total death count is 572,000 with the majority of the cases in the United States, followed by Brazil, India and Russia.


Mlabs may have been roped in by the glove maker for its expansion because of the former's expertise in providing solutions to the pharmaceutical.


In March this year, Mlabs announced that it will provide its video-conferencing products to Ipharmacare Malaysia Sdn Bhd to complement the latter's online pharmaceutical platform.


In return, Ipharmacare will support Mlab's efforts to promote these products, which will include but not limited to video conferencing systems, messaging systems and network solutions, to its platform users and/or independent pharmacies.


Mlabs is a dynamic company and it continues to expand in a drive to improve its revenue and net profit.





The company has announced a private placement of up to 267.4 million new ordinary shares, representing 30 per cent of the total number of issued shares in the company, to independent third-party investors to be identified later.


Based on an illustrative issue price of RM0.0243 per placement share, the gross proceeds to be raised from the proposed private placement will be utilised for working capital, among others.


In June this year Mlabs did announce that it has joined hands with Longhouse Films Sdn Bhd, a Malaysia incorporated film production company situated in Kuching, Sarawak, to revive the failing film production industry in Malaysia.


I am going to try to find out more details on this deal as I find it very interesting. It is about time someone revived the film production industry to put Malaysia on the world map. At least give the industry a chance to try!

Sungguh dahsyat,,, potensinya luar biasa.


Mlabs invests in Kuching production house for online film development
SUNBIZ /11 JUN 2020 / 13:08 H.


PETALING JAYA: Mlabs Systems Bhd will progressively invest up to RM3 million into Kucing-based film production company Longhouse Films Sdn Bhd within the next two years to revive the flailing film production industry in Malaysia.

Mlabs said the objectives behind the partnership include bringing back Malaysian talents from the international entertainment industry to enhance the Malaysian movie industry for Asia and to be part of the content-driven entertainment industry in Asia. It also wants to bring in bigger movie production from China and Korea to Malaysia well as bring China and Asian contents for distribution in South East Asia; as well as exporting and highlighting Malaysian talent to the international level.



This partnership will be long term should Longhouse achieve to build it goals in the entertainment industry in Asia, it added.

Mlabs executive director Steve Tan views its investment in Longhouse as opportune since Longhouse is targeting the international audience in its new movies.

“We anticipate that the return on investment will be positive as the cost of production in Malaysia is significantly lower in comparison to filming overseas such as China, and not to mention that worldwide citizens will soon be facing a severe depletion in online content induced by lockdowns in the US and other European nations as a result of the Covid-19 pandemic. In this case, Longhouse will be well positioned to bridge the demand and supply gap in partnering with major online movie portals such as Youku, iQiyi and Netflix,” Tan said in a statement yesterday.

He added that notwithstanding Longhouse CEO and founder Jon Chiew’s vision and mission, it is more convinced by Chiew’s excellent moviemaking track record and knowledge in the film making industry.

“Mlabs would also have been more hesitant to invest were it not for the movie contracts already awarded to Longhouse by international studios and will be in Longhouse’s pipeline for the next two years such as Magic Moments, Hutan, God of War, Monkey King, Sky & Blue Sea, and Letters from the Future,” explained Tan.

Chiew is a Malaysian film producer equipped with more than 20 years of experience in the content business (including the film production and distribution sector) in China. During his tenure with Huace Pictures, he participated in and produced more than 20 films and partnered with major international studios including 20th Century Fox, Universal Pictures, Sony Pictures, Emperor, Media Asia of Hong Kong, CJ Entertainment and New of Korea.

Most notably, he co-founded Starry Entertainment Beijing in year 2017 that produced one of the biggest China movie mega hit “Hello Mr Billionaire” which scored CN¥2.55 billion in Chinese box office after being released in year 2018.

“Despite all my years filming in China, I have always harboured the intention of returning to Malaysia and tap into the local pool of underappreciated talents. It is my hope to build the brand ‘Made in Malaysia and Made by Malaysians’ in the world stage and create a sustainable ecosystem in the Malaysian creative business whereby local talents are empowered and retained, and the culture and tourism sector in Malaysia will be seen by the world,” said Chiew.

Big business in film-making, Cool :)

Mlabs pumps RM3m into Longhouse Films to drive production in Malaysia
FARZANAH FARVEEN 11 JUNE 2020
film_industry
Facebook Twitter LinkedIn WhatsApp WeChat Telegram Email
Mlabs Systems has partnered with Malaysian film production company Longhouse Films to revive the flailing film production industry in Malaysia. Through a shared subscription agreement, both parties aim to enhance the Malaysia movie industry by bringing back Malaysian talents from the international entertainment industry. In a statement to A+M, a spokesperson from Mlabs said it also looks to bring in bigger movie production from China and Korea to Malaysia, as well as bring China and Asian contents for distribution in Southeast Asia.

The spokesperson added that within the next two years, Mlabs will progressively invest up to RM3 million into Longhouse. Steve Tan, the executive director of Mlabs said the company views its investment in Longhouse as opportune as Longhouse is targeting the international audience in its new movies. Mlabs anticipates that the return on investment will be positive as the cost of production in Malaysia is significantly lower in comparison to filming overseas such as China, and the “severe depletion” in online content induced by lockdowns in the US and other European nations as a result of the COVID-19 pandemic.

“In this case, Longhouse will be well positioned to bridge the demand and supply gap in partnering with major online movie portals such as YOUKU, iQIYI and Netflix. Mlabs would also have been more hesitant to invest were it not for the movie contracts already awarded to Longhouse by international studios and will be in Longhouse’s pipeline for the next two years such as Magic Moments, Hutan, God of War, Monkey King, Sky & Blue Sea, and Letters from the Future,” he added.

Meanwhile, Jon Chiew, CEO and founder of Longhouse said, he aims to build the "Made in Malaysia and Made by Malaysians" brand in the world stage. He is also looking to create a sustainable ecosystem in the Malaysian creative business whereby local talents are empowered and retained, and the culture and tourism sector in Malaysia will be seen by the world.

Jon Chiew is a Malaysian film producer with more than 20 years of experience in the content business in China. During his tenure with production company Huace Pictures, he participated in and produced more than 20 films and partnered with major international studios including 20th Century FOX, Universal Pictures, Sony Pictures, Emperor, Media Asia of Hong Kong, CJ Entertainment and NEW of Korea.

“Despite all my years filming in China, I have always harboured the intention of returning to Malaysia and tap into the local pool of underappreciated talents. Malaysia has many robust and talented people who are able to fluently command several languages but also retain their own ethnic culture in a very profound way,” he added.

With the enforcement of Movement Control Order (MCO), film production jobs have been halted. Recently, the Malaysian Association of Advertising Filmmakers (PPFIM) appealed to the Ministry of Communications and Multimedia Malaysia to allow the industry to resume shooting commercial films during this COVID-19 crisis. The Malaysian government then approved for the filming industry to resume operations after Hari Raya, according to Malay Mail. Citing communications and multimedia minister, Saifuddin Abdullah, it is reported that the approval was given during the National Security Council meeting on 19 May. Malay Mail also reported that production houses are allowed conduct their shoots with a strict standard operating procedure (SOP), while the approval for live programmes to resume is still under discussion.

NetX Holdings Berhad is currently one of the company’s largest shareholder . The other major shareholders are Fintec Global Berhad and Sanston Financial Group Limited, Asset Management Arm,respectively.

Mlabs Systems Berhad Virtual AGM
https://mlabs.com
mlabs systems berhad We've been creating Awesome Since 1992 Unlike conventional video conferencing systems which enables only point -to – point or point – to – multipoint link-ups, MCS is the first of its kind to offer virtually unlimited multipoint-to-multipoint interactivity for desktop computer, Boardroom, Telepresence and High ...

CrystalView HD 9100 · Awards · Get In Touch · AGM Discussed Key Matters · Company Reports

MCS, which is MLABS System’s flagship software product, is being used in Malaysia, Singapore, Thailand, Philippines, Australia, United States, Japan, the Netherlands, France, India, Libya and many other countries.


Unlike conventional video-conferencing systems that enable only point-to-point or point-to-multipoint link-ups, MCS offers virtually unlimited multipoint to multipoint interactivity for notebook, desktop, boardroom and wireless environments.

MLABS Systems Bhd chairman and non-executive director Assoc Prof Dr Sureswaran Ramadass demonstrating the functions of the company's flagship software product, the Multimedia Conferencing System.
The MCS was initially developed by Universiti Sains Malaysia's School of Computer Sciences.

MLABS Systems, a Multimedia Super Corridor (MSC)-status company, started as Multimedia Research Lab Sdn Bhd in 1998, in collaboration with USM.

Among the company’s clients are Multimedia Development Corporation, Malaysia Satellite Services (Measat), Sirim Berhad, Construction Industry Development Board of Malaysia, Malaysia Meterological Services Department and the Penang Government.

Its foreign clients include the City Council of Los Angeles, Singapore's Suntec City Development Pte Ltd, Zurich Capital in New York, Bharti Broadband Services from India, Federal Robotics Institute in Canada, Keio University in Tokyo, Japan and Asia Institute of Technology in Thailand.

Nilai dah muncul kan?, selamat melabur! :)

Date Price Open High Low Volume
2020-12-09 0.120 0.115 0.120 0.115 26,031
2020-12-08 0.115 0.120 0.125 0.115 11,969
2020-12-07 0.120 0.115 0.125 0.110 65,680
2020-12-04 0.115 0.115 0.120 0.115 40,833
2020-12-03 0.120 0.120 0.125 0.115 22,609
2020-12-02 0.120 0.125 0.125 0.115 62,914
2020-12-01 0.130 0.125 0.130 0.120 12,443
2020-11-30 0.125 0.130 0.140 0.125 85,143
2020-11-27 0.135 0.135 0.140 0.130 99,656
2020-11-26 0.135 0.135 0.135 0.130 27,326
2020-11-25 0.135 0.130 0.140 0.130 43,407
2020-11-24 0.140 0.145 0.150 0.125 120,810
2020-11-23 0.145 0.160 0.160 0.145 57,145
2020-11-20 0.155 0.155 0.170 0.145 219,417
2020-11-19 0.155 0.150 0.160 0.145 100,203
2020-11-18 0.150 0.155 0.160 0.145 39,349
2020-11-17 0.150 0.155 0.175 0.140 246,504
2020-11-16 0.155 0.190 0.190 0.150 123,582
2020-11-13 0.190 0.170 0.200 0.170 115,498
2020-11-12 0.170 0.145 0.195 0.145 218,956
2020-11-11 0.240 0.225 0.245 0.220 140,365
2020-11-10 0.225 0.215 0.230 0.210 85,000

It is a dark horse, it can surge unexpectedly or even higher than other stocks as the number of shares outstanding after consol + RI ~ 800mil shares only :)

Good Luck, Guys! Semoga kaya-raya nanti, cheers!

Commentary on Prospects
The Covid-19 pandemic continues to spark concern across the global economy, it remains uncertain when the
virus would be contained at this stage. Bank Negara Malaysia announced that the Malaysia’s Gross Domestic
Product improved from -17.1% in Q2 2020 to -2.7% in Q3 2020. The improvement shows sign of recovery
following the reopening of the economy after the Movement Control Order.
Social distancing SOPs had been imposed in Malaysia to curb the rise of Covid-19 cases, with the restriction in
movement and other measures limiting the close contact of people. However, the Group sees this as an
opportunity to grow the multimedia video conferencing business as it has been an important communication tool
to connect clients, colleagues, business partners and other stakeholders. The Group intends to expand the video
conferencing business by collaborating into the field of telemedicine as well as broadcasting and livestreaming.
Nevertheless, the Group continues to explore potential investment or acquisition in complementary business or
asset.
At this juncture, the Group is in discussion for potential collaboration of providing video conferencing facilities
to healthcare providers. The succession of this collaboration is expected to provide a stable and recurring income
stream via the monthly subscription fees. The demand for telemedicine is expected to grow in future
corresponding to the increase in the demand of healthcare services.
The Group had in August 2020 acquired a 51% equity interest by way of ordinary share subscription and
subscription of RCPS up to RM3.0 million in Longhouse, a film production company. The rationale for investing
into a film production company is to capitalise on the availability of government grants to encourage local film
production and to leverage on our existing technological capabilities that can be applied in film production.
The Group will continuously seek opportunities to expand its business in the ICT industry, complementing the
current business and tap into the ongoing trend of digitalisation of the economy.

banyak cash, ada unit trusts juga

Fair Value Measurement
The financial assets maturing within the next 12 months reasonably approximate their fair values due to the
relatively short-term maturity of the financial instruments.
Fair value hierarchy
The table below analyses financial instrument carried at fair value, by valuation method. The different levels
have been defined as follows:
• Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities.
• Level 2: Inputs other than quoted prices included within Level 1 that are observable for assets
or liabilities, either directly (i.e. as prices) or indirectly (i.e. derived from prices). • Level 3: Inputs for the assets or liabilities that are not based on observable market data
(unobservable inputs).
As at
30.09.2020
As at
30.06.2020
RM’000 RM’000
Group (unaudited) (audited)
Level 1
Unit trust fund 14 14
Trust assets 4,023 4,077
4,037 4,091
The Group does not have any financial liabilities carried at fair value nor any financial instruments classified
as Level 2 and Level 3 as at 30 September 2020.

Hongkong juga ada bisnes , banget baik


On 7 September 2020, the Company subscribed 150,000 new ordinary share at HKD1.00 for total consideration
of HKD150,000 representing 60% shareholdings of Linkodes International Limited.

banyak berita baik akan datang kut?

On 10 August 2020, the Company subscribed 52,000 new ordinary shares at RM1.00 for a total consideration
of RM52,000 representing 51% shareholdings of Longhouse. Upon completion, Longhouse became a 51%
owned subsidiary of the Group

dah masuk China, aiyoh, mungkin berita dari China akan datang kut?

On 15 July 2020, Champagne Carbon Asia Limited incorporated a wholly owned subsidiary, Shenzhen Carbon
Champagne Development Limited (“SCCDL”) with a registered paid up capital of RMB1,000,000.

mlab, sharenya tak banyak , senang naik jika permintaan datang :)

esok barangkali naik roket ke bulan sebelum isnin depan, share baru dan warrant dibuka untuk jualbeli

jumlah syer together with RI ~ 800 mil ++ saja.. baguslah


Events after the End of the Quarter
i. On 1 September 2020, the Company proposed to consolidate of every 10 existing ordinary shares in the
Company into 1 share. The consolidation had been completed on 5 November 2020, in which 1,258,539,027
shares had consolidated into 125,853,870 Consolidated Shares.
ii. On 1 September 2020, the Company proposed renounceable right issue of up to 755,123,412 new shares
together with up to 440,488,657 free detachable warrants in the Company (“Warrant C”) on the basis of 12
Rights Shares together with 7 free Warrants C for every 2 existing shares. The abridged prospectus has been
released to the public on 13 November 2020. The closing date for acceptance and payment for provisional
allotment and excess Rights Shares is on 30 November 2020.

On 19 November 2020, Mlabs Research Sdn Bhd (“Research”), a wholly owned subsdiary of the Company
had entered into a Digital Distribution Agreement with mTouche International Sdn Bhd to promote, market,
and distribute Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel
Coronavirus (SAR-CoV-2) lgM/lgG Rapid Test Kit, and other equivalent products in Malaysia and South
East Asia Region only through the Group’s digital distribution channel.

On 6 October 2020 and 11 November 2020, the Company subscribed Redeemable Convertible Preference
Shares (“RCPS”) in Longhouse Films Sdn Bhd (“Longhouse”) amounted to RM1,000,000.

Segmental Information
Segmental information is presented in respect of the Group’s business and geographical segments. The primary
format of business segments, are based on the Group’s management and internal reporting structure.
Business segments
The Group is organised into business units based on their products and services, and has three reportable
segments as follows:

Research and development, and :
assembling
Research and development, assembling and trading of multimedia
video conferencing system, and mobile application solutions
Films production : Movie production
Trading : Trading of champagne, kitchen equipment and related products

Latest***********

JOINT PRESS RELEASE
MLABS SYSTEMS BERHAD AND MTOUCHE TECHNOLOGY BERHAD DIGITAL DISTRIBUTION AGREEMENT
The Board of Directors of Mlabs Systems Berhad (“MLABS”) and MTouche Technology Berhad “MTOUCHE”) wishes to inform that Mlabs Research Sdn. Bhd. (formerly known as Multimedia Research Lab Sdn Bhd) (“MLABS Research”), a wholly owned subsidiary of the MLABS, had on 19th November 2020 entered into a Digital Distribution Agreement (the “Agreement”) with mTouche International Sdn. Bhd. (“MISB”), a wholly owned subsidiary of the MTOUCHE to promote, market, and distribute Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel Coronavirus (SAR-CoV-2) lgM/lgG Rapid Test Kit, and other equivalent products in Malaysia through MLABS digital distribution channel.
MLABS will utilize the existing collaboration partner, iPharmacare (Malaysia) Sdn. Bhd.’s Online Pharmaceutical Platform as the main channel to promote, market, and distribute the Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel Coronavirus (SAR- CoV-2) lgM/lgG Rapid Test Kit to Ministry of Health, Malaysia (MoH) recognized public and private pathology laboratory/hospital.
The Agreement is for a period of one (1) year, commencing on and from 19th November 2020, renewable thereafter for successive one (1) year unless otherwise mutually extended or terminated. Either party may terminate the Agreement upon delivery of written notice at least 30 days prior to such termination.
Similar to all business entities, the risk factors affecting the execution of the Agreement, including but not limited to business risks such as prudent financial management, changes in political, economic and regulatory conditions. However, the Board of MLABS and MTOUCHE will continue to exercise due care in considering the risks associated with the Agreement and will take appropriate measures in planning the successful execution of the Agreement.
The Agreement being incurred in the ordinary course of business, is not subject to the approval of the shareholders of MLABS and MTOUCHE.
None of the Directors and/or other major shareholders of MLABS and MTOUCHE and/or any persons connected to them have any interest, direct or indirect, in relation to the Agreement.
The Board of MLABS and MTOUCHE, after due consideration, is of the opinion that the Agreement is in the best interest of the both Parties.

cash rich :) even before RI. :) no wonder tak perlu borrowings.

CONSOLIDATED INTERIM FINANCIAL STATEMENTS
FOR THE QUARTER ENDED 30 SEPTEMBER 2020

CONSOLIDATED STATEMENT OF CASH FLOWS
CASH AND CASH EQUIVALENTS

Net changes 6,428 (8,822)
Effects of changes in foreign exchange rate 303 3
Brought forward 22,490 22,591
Carried forward 29,221 13,772
Cash and cash equivalents at the end of the financial period comprise the following:
Cash and bank balances and short-term funds 29,221 13,772

he might emerge as a major shareholder like in netx after RI :)

01 Sep 2020 01 Sep 2020 Acquired 1,000,000 MR TAN SIK EEK

Maybe, emerge as the largest shareholder after RI :) wait for annoucement next week


Netx is a major shareholder of Mlab.
Indirect (units) 12,320,000
Indirect (%) 9.79
Total (units) 12,320,000
Total (%) 9.79
Date of Notice 09-Dec-2020

a blessing in disguise for mlab :)

Since Covid-19 was declared a global pandemic by the World Health Organisation on 11 March 2020, the world has
witnessed large scale of restrictive MCO as Governments, and health services around the world attempted to contain
the virus spread by restricting human interactions through strict social distancing. No one could not have fathomed the
magnitude, duration and severity that the Covid-19 pandemic would inflict on the world. The extensive enforcement of
MCO has curtailed economic activities resulting in businesses including the Group becoming adversely affected. Against
this backdrop of unprecedented world crisis, in the coming year ahead, we would expect to encounter continuing market
uncertainties and volatilities which will continue to affect the Group on multiple fronts. We expect challenges in revenue
generation, financial performance and maintenance of adequate liquidity.
The Covid-19 pandemic has also caused significant changes in business practices globally where businesses and
companies pivot towards increased dependence on and use of technology as a tool to manage business operations. As
a digitalisation solution company, this shift has created market opportunities which the Group intends to focus on. We
see strong potential growth in our web conferencing products that provide solutions for virtual meetings for companies,
business forums, telemedicine and prescriptions, distance learning and numerous types of business solutions that can
benefit from our web conferencing solutions amidst the ongoing social distancing, travel restrictions, and limited physical
gathering still imposed with the resurgence of Covid-19 cases worldwide. We will be building our own broadcasting and
livestreaming centre fitted with the state-of-the-art broadcasting equipment to meet such demand for virtual events,
meetings, social media conventions.
In light of the unprecedented Covid-19 pandemic globally, the Malaysian Government has imposed containment
measures since mid-March 2020 through the implementation of the MCO. While the Malaysian economy is expected to
be significantly affected by the MCO, the Group sees this as an opportunity for it to grow as web conferencing solutions
have emerged as an important means of communication between colleagues, clients, business partners and other
stakeholders during this period, while social distancing is maintained. Furthermore, the deployment of 5G technology is
expected to address one of the major issues in web conferencing, which is the stability and speed of internet. Therefore,
the Group foresees that the widespread usage of 5G technology in the near future will lead to huge potential in the
videoconferencing industry.
We are revamping our Pacifica2U e-commerce platform to increase product offerings and improve customers’ experience.
To complement our existing digitalisation solution products, we will be rolling out an enterprise e-business card mobile
application solution with e-KYC function that could be embedded with other systems (e.g. banking & financial, insurance,
medical and others) to replace conventional business cards and allows for seamless customer information capturing
process to increase contactless solution given the rise of Covid-19 cases. Inbase Partners Limited our subsidiary that
specializes in digital assets advisory and investment whose operations were affected by the Covid-19 pandemic is
expected to gradually improve to normal in the coming year.

Employees etc masih rugi investing in mlab ... sabar ya :)

Employee Shares Option Scheme
183,499,000 shares were issued to eligible employees during FYE 2020 at the prices between RM0.015 to RM0.03 per
share under the Group’s employees’ share option scheme.
On 06 August 2020, 65,000,000 shares were issued to eligible employees at a price of RM0.05 per share under the
Group’s employees share option scheme.
Warrants
On 29 November 2019, 80,000 units of Warrants 2010/2020 were converted into ordinary shares at an exercise price of
RM0.09 per share.
Private Placements
On 29 April 2020, the Group completed a private placement of 80,158,000 of new shares representing 10% of the
Company’s total issued share capital at an issuance price of RM0.0184 per share. The said private placements raised total
proceeds of RM1.48 million for the purpose of working capital of the Group of RM1.40 million and fee expenses arising
for the private placement exercise of RM0.08 million.
On 22 July 2020, the Group completed another private placement of 267,365,000 new shares representing 30% of the
Company’s total issued share capital at an issuance prices ranging from RM0.0315 to RM0.0452 per share. The said
private placements raised total proceeds of RM9.24 million for the purpose of planned marketing expenses for Let’s
Talk mobile application of RM3.0 million, working capital of the Group of RM5.94 million and fee expenses arising for the
private placement exercise of RM0.3 million.
Share Consolidation and Rights Issue with Warrants
On 20 October 2020, we obtained the shareholders’ approval to embark on a fund-raising corporate exercise for the
purpose of business expansion and working capital for the Group. The corporate exercise entailed a share consolidation
of every 10 existing ordinary shares in Mlabs (“Mlabs shares” or “shares”) into 1 Mlabs share. This was followed by a
Renounceable Rights Issue of up to 755,123,412 new shares (“Rights Shares”) together with up to 440,488,657 free
detachable warrants in Mlabs (“Warrants C”) on the basis of 12 Rights Shares together with 7 free Warrants C for every 2
shares (Proposed Rights Issue with Warrants”).
This corporate exercise aims to raise between RM10.0 million under a minimum scenario and RM67.96 million under a
maximum scenario. The proceeds from the Proposed Rights Issue with Warrants will be utilised for the following:
Proposed Utilisation of Proceeds
Expected timeframe for
utilisation from completion
of the Proposed Rights Issue
with Warrants
Minimum
Scenario
(RM’000)
Minimum
Scenario
(RM’000)
Remote meeting and videotelephony enablers within 36 months 8,000 23,000
Broadcasting and livestreaming centre within 6 months - 7,600
Acquisition and/or investments in complementary
business and/or assets
within 24 months - 25,000
Working Capital within 24 months 1,200 11,561
Estimated expenses for the Proposals immediate 800 800
Total 10,000 67,961
This corporate exercise is expected to be completed by December 2020.

cool, :) should be better now

The Covid-19 pandemic has had adverse effects mainly on the Group’s overseas’ activities due to the restrictive
movement control order (“MCO”) imposed in these countries which severely curtailed economic activities. Our business
collaboration projects in Thailand and Laos were halted for several months. As a result, the development and rollout of our
on-line e-commerce platform (JJ Shopping) and e-wallet payment application in Laos have been delayed. Inbase Partners
Limited our subsidiary in Taiwan also saw a reduction in revenue due to the curtailment of economic activities during the
active phase of the Covid-19 pandemic in Taiwan

We had better performance in our domestic market for this financial year. We made headway in our web conferencing
solution despite operating under MCO environment,
(i) During the year, we had a soft launch of our mobile chat application - Let’s talk which is available in Android and
iOS. The application shows promising start and contributed revenue for the Group since its first release. The Group
is still enhancing the application to increase its content and security features with the aim to increase our customer
base to achieve better economic returns.
(ii) We entered into a strategic partnership with Servex (Malaysia) Sdn Bhd, a well-known Information, Communication,
and Technology (“ICT”) distribution company, taking advantage of their vast distribution network of high-end ICT
hardware to complement our web conferencing solution.
(iii) We have a collaboration with Cisco that gives us access to their vast range of collaborative solutions using the
highly secured Webex web conferencing solution and related hardware that are able to convert any space required
into a state-of-the-art virtual web conferencing centre.
There were considerable interests shown in our enhanced web conferencing products during the MCO period as viable
solutions to host virtual meetings and other types of related deployments due to the ongoing social distancing, limited
physical gathering and restrictive travelling to curb the spread of Covid-19 virus. We succeeded in increasing our clientele
base for our enhanced web conferencing products and this interest is expected to lead to strong opportunities for our
web conferencing products in the coming year.
During the year under review, the Group had in August 2020 acquired a 51% equity interest by way of ordinary share
subscription and subscription of Redeemable Convertible Preference Shares up to RM3.0 million in Longhouse Films
Sdn. Bhd., a film production company. The rationale for investing into a film production company is to capitalise on
the availability of government grants to encourage local film production and to leverage on our existing technological
capabilities that can be applied in film production.

mlab is gearing free company as per its annual report 2020... better wait till next week :)


Gearing and Capital Resources
The Group has no borrowings as at 30 June 2020. Our business operations are financed by a combination of internal and
external sources of funds. Internal sources of funds comprise mainly shareholders’ equity and cash generated from our
operations, while external source of funds comprises corporate exercise and credit terms granted by our suppliers. Credit
terms granted to us by our suppliers range from 30 to 90 days.
The management believes that after taking into account our cash and bank balances as well as the funds envisaged to
be generated from our business operations, we will have adequate working capital to meet our present and foreseeable
day-to-day business operation requirements.

JOINT PRESS RELEASE
MLABS SYSTEMS BERHAD AND MTOUCHE TECHNOLOGY BERHAD DIGITAL DISTRIBUTION AGREEMENT
The Board of Directors of Mlabs Systems Berhad (“MLABS”) and MTouche Technology Berhad “MTOUCHE”) wishes to inform that Mlabs Research Sdn. Bhd. (formerly known as Multimedia Research Lab Sdn Bhd) (“MLABS Research”), a wholly owned subsidiary of the MLABS, had on 19th November 2020 entered into a Digital Distribution Agreement (the “Agreement”) with mTouche International Sdn. Bhd. (“MISB”), a wholly owned subsidiary of the MTOUCHE to promote, market, and distribute Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel Coronavirus (SAR-CoV-2) lgM/lgG Rapid Test Kit, and other equivalent products in Malaysia through MLABS digital distribution channel.
MLABS will utilize the existing collaboration partner, iPharmacare (Malaysia) Sdn. Bhd.’s Online Pharmaceutical Platform as the main channel to promote, market, and distribute the Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel Coronavirus (SAR- CoV-2) lgM/lgG Rapid Test Kit to Ministry of Health, Malaysia (MoH) recognized public and private pathology laboratory/hospital.
The Agreement is for a period of one (1) year, commencing on and from 19th November 2020, renewable thereafter for successive one (1) year unless otherwise mutually extended or terminated. Either party may terminate the Agreement upon delivery of written notice at least 30 days prior to such termination.
Similar to all business entities, the risk factors affecting the execution of the Agreement, including but not limited to business risks such as prudent financial management, changes in political, economic and regulatory conditions. However, the Board of MLABS and MTOUCHE will continue to exercise due care in considering the risks associated with the Agreement and will take appropriate measures in planning the successful execution of the Agreement.
The Agreement being incurred in the ordinary course of business, is not subject to the approval of the shareholders of MLABS and MTOUCHE.
None of the Directors and/or other major shareholders of MLABS and MTOUCHE and/or any persons connected to them have any interest, direct or indirect, in relation to the Agreement.
The Board of MLABS and MTOUCHE, after due consideration, is of the opinion that the Agreement is in the best interest of the both Parties.

OTHERS MLABS SYSTEMS BERHAD - DIGITAL DISTRIBUTION AGREEMENT WITH MTOUCHE INTERNATIONAL SDN. BHD.

MLABS SYSTEMS BERHAD

Type Announcement
Subject OTHERS
Description MLABS SYSTEMS BERHAD
- DIGITAL DISTRIBUTION AGREEMENT WITH MTOUCHE INTERNATIONAL SDN. BHD.
The Board of Directors of Mlabs Systems Berhad (“Mlabs” or the “Company”) wishes to inform that Mlabs Research Sdn. Bhd. (“Mlabs Research”), a wholly owned subsidiary of the Company, had on 19 November 2020 entered into a Digital Distribution Agreement (“Agreement”) with mTouche International Sdn. Bhd. (“MISB”) to promote, market, and distribute Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel Coronavirus (SAR-CoV-2) lgM/lgG Rapid Test Kit, and other equivalent products in Malaysia and South East Asia Region only through Mlabs digital distribution channel.



MISB is a wholly owned subsidiary of mTouche Technology Berhad which the group is engaged in the provision of mobile value-added services and digital medial marketing to more than 40 mobile network operators, who are reaching out to more than 640 million subscribers throught its operation in South East Asia market and Hong Kong.



The Agreement is to a period of one (1) year, commencing on and from 19 November 2020, unless otherwise mutually extended or terminated. Either party may terminate the Agreement upon delivery of written notice at least 30 days prior to such termination.



The Agreement will not have any effects on the share capital and shareholding structure of the Company. However, it is expected to have positive contribution to the earnings and net assets of Mlabs Group.



Similar to all business entities, the risk factors affecting the execution of the Agreement, including but not limited to business risks such as prudent financial management, changes in political, economic and regulatory conditions. However, the Board will continue to exercise due care in considering the risks associated with the Agreement and will take appropriate measures in planning the successful execution of the Agreement.



The Agreement being incurred in the ordinary course of business, is not subject to the approval of the shareholders.



None of the Directors and/or other major shareholders of the Company and/or any persons connected to them have any interest, direct or indirect, in relation to the Agreement.



The Board, after due consideration, is of the opinion that the Agreement is in the best interest of the Group.



This announcement is dated 19 November 2020.

MLAB - RENOUNCEABLE RIGHTS ISSUE OF 755,123,220 NEW ORDINARY SHARES IN MLAB ("MLAB SHARES") ("RIGHTS SHARES") TOGETHER WITH 440,488,340 FREE DETACHABLE WARRANTS IN MLAB ("WARRANTS C") ON THE BASIS OF 12 RIGHTS SHARES TOGETHER WITH 7 FREE WARRANTS C FOR EVERY 2 MLAB SHARES HELD BY THE ENTITLED SHAREHOLDERS OF MLAB ("RIGHTS ISSUE WITH WARRANTS")

MLABS SYSTEMS BERHAD

Kindly be advised that the abovementioned Company's additional 755,123,220 new ordinary shares issued pursuant to the aforesaid Rights Issue with Warrants will be granted listing and quotation with effect from 9.00 a.m., Monday, 14 December 2020.



We are also pleased to advise that MLAB’s 440,488,340 Warrants C issued pursuant to the Rights Issue with Warrants will be admitted to the Official List of the Exchange and the listing and quotation of the Warrants C on the ACE Market, will be granted with effect from 9.00 a.m., Monday, 14 December 2020.

Better wait till next monday or week, maybe, mgmt buyout also like netx version

Mlab’s RI was oversubscribed but netx was undersubscribed but netx Flyed to 24sen from 14sen on a particular day. Mlab is a darkhorse, dont write it off yet. A remarkable new substantial shareholder can emerge from RI. :)

NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING MLABS SYSTEMS BERHAD ("MLABS" OR THE "COMPANY") RIGHTS ISSUE WITH WARRANTS

MLABS SYSTEMS BERHAD

Type Announcement
Subject NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description MLABS SYSTEMS BERHAD ("MLABS" OR THE "COMPANY")

RIGHTS ISSUE WITH WARRANTS
(For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Abridged Prospectus dated 13 November 2020 issued by the Company in relation to the Rights Issue with Warrants.)



We refer to the Abridged Prospectus dated 13 November 2020.



On behalf of the Board, Mercury Securities wishes to announce that pursuant to the close of acceptance, excess applications and payment for the Rights Shares with Warrants C at 5.00 p.m. on 30 November 2020, the Company had received valid acceptances and excess applications for a total of 806,441,306 Rights Shares, representing an over-subscription of 6.8% over the total number of Rights Shares available for subscription under the Rights Issue with Warrants.



Details of such valid acceptances and excess applications received are as follows:-





No. of Rights Shares

% of total issue

Total valid acceptances

621,805,762

82.3

Total valid excess applications

184,635,544

24.5

Total valid acceptances and excess applications

806,441,306

106.8

Total Rights Shares available for subscription

755,123,220

100.0

Over-subscription

51,318,086

6.8


Successful applicants of the Rights Shares will be given Warrants C on the basis of 7 Warrants C for every 12 Rights Shares successfully subscribed for. The Excess Rights Shares with Warrants C will be allotted in a fair and equitable manner in the following priority:-



(i) firstly, to minimise the incidence of odd lots;



(ii) secondly, on a pro-rata basis and in board lots, to the Entitled Shareholders who have applied for Excess Rights Shares with Warrants C, taking into consideration their respective shareholdings in the Company as at the Entitlement Date;



(iii) thirdly, on a pro-rata basis and in board lots, to the Entitled Shareholders who have applied for Excess Rights Shares with Warrants C, taking into consideration the quantum of their respective Excess Rights Shares with Warrants C Applications; and



(iv) finally, on a pro-rata basis and in board lots, to the transferee(s) and/or renouncee(s) who have applied for Excess Rights Shares with Warrants C, taking into consideration the quantum of their respective Excess Rights Shares with Warrants C Applications.



The Excess Rights Shares with Warrants C will firstly be allocated to minimise the odd lots (if any) held by each applicant of Excess Rights Shares with Warrants C. Thereafter, the allocation process will perform items (ii), (iii) and (iv) in succession. Any remaining balance of Excess Rights Shares with Warrants C will be allocated by performing the same sequence of allocation i.e. items (ii), (iii) and (iv) again in succession until all Excess Rights Shares with Warrants C are allotted.



Notwithstanding the foregoing, the Board reserves the right to allot any Excess Rights Shares with Warrants C applied for under Part I(B) of the RSF in such manner as it deems fit and expedient and in the best interests of the Company subject always to such allocation being made on a fair and equitable basis, and that the intention of the Board as set out in (i), (ii), (iii) and (iv) above is achieved. The Board also reserves the right at its absolute discretion not to accept any application for Excess Rights Shares with Warrants C, in full or in part, without assigning any reason thereof.



The Rights Shares and Warrants C are expected to be listed on the ACE Market of Bursa Securities on 14 December 2020.



This announcement is dated 7 December 2020.

Mlabs Systems Bhd is going to provide its video-conferencing products to Ipharmacare Malaysia Sdn Bhd to complement the latter's online pharmaceutical platform.

In return, Ipharmacare will support Mlab's efforts to promote these products, which will include but not limited to video conferencing systems, messaging systems and network solutions, to its platform users and/or independent pharmacies.

吉隆坡1日讯）MLAB系统（MLAB,0085,创业板科技组）拟将10股整合成1股，再以整合后2股配12送6比例发售附加股和派送凭单，最多筹资5285万9000令吉来购置设备、收购和投资辅助业务，以及作为营运资本。

该公司发文告表示，建议将10股整合成1股，再以整合后2股配12送6比例发售最多7亿5512万3412股附加股，以及配送4亿4048万8657单位凭单，附加股发售价和凭单行使价将由董事部稍后决定。

假设附加股发售价为每股7仙，MLAB系统预期最多筹措5285万9000令吉，其中2300万令吉用作远程会议和视频电话启动器、760万令吉广播与直播中心、1500万令吉收购和投资辅助业务及资产、645万9000令吉为营运资本。

整个企业活动预期在今年下半年完成，届时MLAB系统缴足资本将从现有的5485万1682令吉扩大至1亿5175万9187令吉。

Netx , pemegang terbesar mlab kan? :) sabar ya


TOP 10 INVESTORS (AS OF LATEST FILING)
INVESTOR NAME % O/S POSITION (M Shares) POSITION CHG (M) VALUE(M USD) FILING DATE FILING SOURCE
Phang (Yee Hoong) 2.35 2.96 2.26 0.28 23-Sep-2019 Other Substantial/Declarable
First United Technology Ltd. 1.51 13.32 0.00 0.96 29-Sep-2020 Other Substantial/Declarable
Asiabio Capital Sdn. Bhd. 0.85 7.51 0.00 0.54 29-Sep-2020 Other Substantial/Declarable
Ace Solution Investments Limited 0.79 1.00 0.00 0.10 23-Sep-2019 Other Substantial/Declarable
Kuek (Fook Hai) 0.60 0.75 0.13 0.07 23-Sep-2019 Other Substantial/Declarable
Tan (Chee Seng) 0.40 0.50 0.11 0.05 23-Sep-2019 Other Substantial/Declarable
Yeoh (Kian Chin) 0.32 0.41 0.03 0.04 23-Sep-2019 Other Substantial/Declarable
Ong (Chee Choon) 0.32 0.40 0.40 0.04 23-Sep-2019 Other Substantial/Declarable
How (Bee Hua) 0.30 0.38 -0.22 0.04 23-Sep-2019 Other Substantial/Declarable
Toh (Cowan) 0.29 0.36